Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management

MLA

Masaru Tani, et al. “Cumulative Incidence and Risk Factors for Medication-Related Osteonecrosis of the Jaw during Long-Term Prostate Cancer Management.” Scientific Reports, vol. 14, no. 1, June 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-024-64440-7.

APA

Masaru Tani, Koji Hatano, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Atsunari Kawashima, & Norio Nonomura. (2024). Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management. Scientific Reports, 14(1), 1–11. https://doi.org/10.1038/s41598-024-64440-7

Chicago

Masaru Tani, Koji Hatano, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, et al. 2024. “Cumulative Incidence and Risk Factors for Medication-Related Osteonecrosis of the Jaw during Long-Term Prostate Cancer Management.” Scientific Reports 14 (1): 1–11. doi:10.1038/s41598-024-64440-7.